Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor*.
Chemistry
; 26(68): 15839-15842, 2020 Dec 04.
Article
em En
| MEDLINE
| ID: mdl-32794211
Single chemical entities with potential to simultaneously interact with two binding sites are emerging strategies in medicinal chemistry. We have designed, synthesized and functionally characterized the first bitopic ligands for the CB2 receptor. These compounds selectively target CB2 versus CB1 receptors. Their binding mode was studied by molecular dynamic simulations and site-directed mutagenesis.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Receptor CB2 de Canabinoide
Idioma:
En
Revista:
Chemistry
Assunto da revista:
QUIMICA
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Espanha